Literature DB >> 8287949

Production of acute bronchiolitis in guinea-pigs by human respiratory syncytial virus.

R G Hegele1, P J Robinson, S Gonzalez, J C Hogg.   

Abstract

Respiratory syncytial virus (RSV) is the most important cause of acute bronchiolitis in young children, and is implicated in the pathogenesis of paediatric asthma. The present studies were designed to develop a model of acute RSV bronchiolitis in young guinea-pigs, that could be used to study the mechanisms of the acute bronchiolitis and its sequelae. Anaesthetized, one month old guinea-pigs received either 4 x 10(3) plaque forming units of Long strain human RSV or uninfected cell culture medium intranasally. Bronchiolar inflammation was assessed 6 days (n = 10 RSV-inoculated; n = 10 controls) and 14 days (n = 10 RSV-inoculated; n = 9 controls) postinoculation using a semiquantitative histological scoring system. Viral replication within the lung was evaluated by culture, and the intrapulmonary distribution of viral antigens was evaluated by immunohistochemistry. The RSV-inoculated group showed histological evidence of acute bronchiolitis 6 days after inoculation, which subsided by Day 14. Replicating virus was cultured from the lungs of 9 out of 10 RSV-inoculated animals on Day 6, and 2 out of 10 animals on Day 14, with no growth from control animals. Viral antigens were identified primarily within airway epithelial cells on Day 6, and within alveolar macrophages on Day 14. Intranasal inoculation of human RSV into guinea-pigs provides a model of acute RSV bronchiolitis that may facilitate the study of both the pathogenesis of acute infection and the possible role of RSV in the subsequent development of nonspecific bronchial hyperresponsiveness in children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287949

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Essential roles of NF-kappaB and C/EBP in the regulation of intercellular adhesion molecule-1 after respiratory syncytial virus infection of human respiratory epithelial cell cultures.

Authors:  B A Chini; M A Fiedler; L Milligan; T Hopkins; J M Stark
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies.

Authors:  Rene Alvarez; Kevin S Harrod; Wun-Ju Shieh; Sherif Zaki; Ralph A Tripp
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies.

Authors:  H J Streckert; S Philippou; F Riedel
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Cell cycle arrest by transforming growth factor beta1 enhances replication of respiratory syncytial virus in lung epithelial cells.

Authors:  John D Gibbs; Douglas M Ornoff; Heather A Igo; Jennifer Y Zeng; Farhad Imani
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

Review 5.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

6.  Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.

Authors:  Susana Chávez-Bueno; Asunción Mejías; Ana M Gómez; Kurt D Olsen; Ana M Ríos; Mónica Fonseca-Aten; Octavio Ramilo; Hasan S Jafri
Journal:  Virol J       Date:  2005-05-25       Impact factor: 4.099

Review 7.  Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.

Authors:  U P Kodavanti; D L Costa; P A Bromberg
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

Review 8.  Animal models of respiratory syncytial virus infection.

Authors:  Geraldine Taylor
Journal:  Vaccine       Date:  2016-11-29       Impact factor: 3.641

9.  Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities.

Authors:  Peter Mastrangelo; Michael J Norris; Wenming Duan; Edward G Barrett; Theo J Moraes; Richard G Hegele
Journal:  Vaccines (Basel)       Date:  2017-09-19

Review 10.  Small Animal Models of Respiratory Viral Infection Related to Asthma.

Authors:  Mingyuan Han; Charu Rajput; Tomoko Ishikawa; Caitlin R Jarman; Julie Lee; Marc B Hershenson
Journal:  Viruses       Date:  2018-12-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.